Allurion Technologies Inc. (ALUR)
| Market Cap | 101.11M |
| Revenue (ttm) | 53.47M |
| Net Income (ttm) | -82.30M |
| Shares Out | 47.92M |
| EPS (ttm) | -2.31 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 174,507 |
| Open | 1.880 |
| Previous Close | 1.940 |
| Day's Range | 1.752 - 2.300 |
| 52-Week Range | 1.560 - 10.940 |
| Beta | 0.01 |
| Analysts | Strong Buy |
| Price Target | 5.00 (+136.97%) |
| Earnings Date | May 14, 2024 |
About ALUR
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts. [Read more]
Financial Performance
In 2023, ALUR's revenue was $53.47 million, a decrease of -16.73% compared to the previous year's $64.21 million. Losses were -$82.30 million, 102.5% more than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for ALUR stock is "Strong Buy." The 12-month stock price forecast is $5.0, which is an increase of 136.97% from the latest price.
News
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports First Quarter 2024 Financial Results and Provides Business Update.
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three oral scientific presentations at the 12th Con...
Allurion Announces Preliminary First Quarter 2024 Results
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary, unaudited results for the fi...
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
NATICK, Mass.--(BUSINESS WIRE)--Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments.
Allurion Expands Virtual Care Suite to the United States
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the commercial availability of its comprehensive Vi...
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance.
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the appointment of its newest board member and Audi...
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
NATICK, Mass.--(BUSINESS WIRE)--Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024.
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Brendan Gibbons as its new Chief ...
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that the Somerset NHS Foundation Trust (FT) is the ...
World first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that the Somerset NHS Foundation Trust (FT) is the ...
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced further expansion of its Virtual Care Suite (VCS) di...
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the publication of a randomized, double-blind study...
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
NATICK, Mass.--(BUSINESS WIRE)--Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook.
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced results of research that highlighted the positive i...
Allurion's Digital Platform Gains Traction with Expanded Strategic Partnership
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced an expanded commercial agreement with Weight Doctors...
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
NATICK, Mass.--(BUSINESS WIRE)--Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update.
Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023
NATICK, Mass.--(BUSINESS WIRE)--Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023.
Allurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion Balloon
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the completion of patient enrollment in its AUDACITY trial. AUDACITY is...
Allurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced acceptance of five abstracts that will be presented at Obesity Week 202...
Allurion Featured at the 2023 International Bariatric Club Oxford University World Congress
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced its participation in the 4th International Bariatric Club (IBC) Oxford ...
Allurion Introduces Coach Iris: A 24/7 Generative AI-Powered Weight Loss Coach
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, has today unveiled Coach Iris, a new generative AI-powered health coach designed to enh...
Allurion Announces Acceptance of Nine Scientific Presentations at IFSO 2023 World Congress
NATICK, Mass.--(BUSINESS WIRE)--Allurion (NYSE: ALUR), a company dedicated to ending obesity, today announced the acceptance of nine scientific presentations at the upcoming 26th World Congress of the...
Allurion Debuts as a Publicly Traded Company on the NYSE
NATICK, Mass.--(BUSINESS WIRE)--Allurion Debuts as a Publicly Traded Company on the NYSE.
Allurion Technologies, Inc. and Compute Health Acquisition Corp. Announce Updated Terms to Warrant Agreement Amendment
NATICK, Mass. & WILMINGTON, Del.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion”), a company dedicated to ending obesity, and Compute Health Acquisition Corp. (“Compute Health”) (NYSE: CPUH)...